Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

McGill University

$150,000.00

Acute effects of non-invasive repetitive transcranial magnetic stimulation (rTMS) in the management of chronic orofacial pain and problematic opioid use.

EF 2020-21

Résumé
Temporomandibular joint disorders (TMD) are common chronic pain conditions of the face and jaw that impact significantly the well-being and quality of life of people suffering from them. Chronic TMD pain is challenging to treat and many patients do not respond well to usual treatments. Moreover, medications such as opioids are associated with different risks and side-effects. Hence, the investigation of newer and safer treatments becomes highly relevant. "Repetitive transcranial magnetic stimulation" (rTMS) is a safe and non-invasive technique used to stimulate the brain and potentially change neurons. rTMS has proven to improve pain and addiction, but its use in TMD has not been tested yet. Thus, we aim to assess if rTMS can improve pain and opioid problems in TMD participants. This thesis project is divided in two studies. One study is focused on pain, where 30 TMD participants not taking opioids will be recruited, and the other is focused on opioids, where another 30 TMD participants taking opioids will be recruited. In both studies, each participant will have two separate treatment sessions, one where they will receive active rTMS, and one where they will receive a "sham" (i.e., fake) treatment with an identical device but with limited power. The order of the sessions will be random and neither the participant nor the staff will know when the patients receive one or the other. Following each treatment session (rTMS or sham), participants will complete electronic diaries at home, twice daily, for one week. These diaries will ask questions about pain intensity and pain interference with daily activities. Patients who use opioids will also answer diary questions about opioid use. We expect that rTMS decreases pain intensity, pain interference, and opioid problems in TMD participants. This project is novel and important, as its findings could support the use of a new and safe treatment for improving pain, opioid problems, and suffering associated to TMD.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
437125
Name
Herrero Babiloni Alberto
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Acute effects of non-invasive repetitive transcranial magnetic stimulation (rTMS) in the management of chronic orofacial pain and problematic opioid use.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Chronic Pain; Craving; Opioid; Temporomandibular Disorders; Transcranial Magnetic Stimulation
Abstract
Temporomandibular joint disorders (TMD) are common chronic pain conditions of the face and jaw that impact significantly the well-being and quality of life of people suffering from them. Chronic TMD pain is challenging to treat and many patients do not respond well to usual treatments. Moreover, medications such as opioids are associated with different risks and side-effects. Hence, the investigation of newer and safer treatments becomes highly relevant. "Repetitive transcranial magnetic stimulation" (rTMS) is a safe and non-invasive technique used to stimulate the brain and potentially change neurons. rTMS has proven to improve pain and addiction, but its use in TMD has not been tested yet. Thus, we aim to assess if rTMS can improve pain and opioid problems in TMD participants. This thesis project is divided in two studies. One study is focused on pain, where 30 TMD participants not taking opioids will be recruited, and the other is focused on opioids, where another 30 TMD participants taking opioids will be recruited. In both studies, each participant will have two separate treatment sessions, one where they will receive active rTMS, and one where they will receive a "sham" (i.e., fake) treatment with an identical device but with limited power. The order of the sessions will be random and neither the participant nor the staff will know when the patients receive one or the other. Following each treatment session (rTMS or sham), participants will complete electronic diaries at home, twice daily, for one week. These diaries will ask questions about pain intensity and pain interference with daily activities. Patients who use opioids will also answer diary questions about opioid use. We expect that rTMS decreases pain intensity, pain interference, and opioid problems in TMD participants. This project is novel and important, as its findings could support the use of a new and safe treatment for improving pain, opioid problems, and suffering associated to TMD.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Herrero Babiloni, Alberto
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~